Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
MiRNA in situ hybridization in circulating tumor cells - MishCTC
Francisco G. Ortega
, Jose A. Lorente
, Jose L. Garcia Puche
, Maria P. Ruiz
, Rosario M. Sanchez-Martin
, Diego De Miguel-Pérez
, Juan J. Diaz-Mochon
, Maria J. Serrano
Research output
:
Contribution to journal
›
Article
›
peer-review
41
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'MiRNA in situ hybridization in circulating tumor cells - MishCTC'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
In Situ Hybridization
100%
MicroRNA
100%
Circulating Tumor Cells
100%
MicroRNA-21 (miR-21)
88%
Epithelial-to-mesenchymal Transition
22%
Cytokeratin Expression
22%
Clinical Application
11%
Cancer Patients
11%
Blood Samples
11%
Tumor Cell Lines
11%
Hematopoietic Cells
11%
Peripheral Blood
11%
MCF-7 Cells
11%
Immunocytochemistry
11%
Positive Samples
11%
Epithelial Tumor
11%
Cytokeratin
11%
Nontumor
11%
Epithelial Tumor Cells
11%
MCF10A Cells
11%
Target miRNA
11%
Immunomagnetic Selection
11%
Fluorescence Amplification
11%
OncomiRNA
11%
Locked nucleic Acid Probe
11%
Enzyme-labeled Fluorescence
11%
Veterinary Science and Veterinary Medicine
Neoplasm
100%
In Situ Hybridization
100%
MicroRNA
83%
Cytokeratin
25%
Hematopoietic Cell
8%
Cancer
8%
Blood Sample
8%
Immunocytochemistry
8%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
In Situ Hybridization
100%
Cytokeratin
30%
Mesenchymal-Epithelial Transition
20%
Enzyme
10%
Immunocytochemistry
10%
Locked Nucleic Acid
10%
Nucleic Acid Probe
10%
Hematopoietic Cell
10%
Immunology and Microbiology
Circulating Tumor Cell
100%
In Situ Hybridization
100%
Epithelial Mesenchymal Transition
22%
Tumor Cell Line
11%
Hematopoietic Cell
11%
Immunocytochemistry
11%
MCF-10A Cell Line
11%
Nucleic Acid Probe
11%